|
1
|
Shaul YD, Freinkman E, Comb WC, Cantor JR,
Tam WL, Thiru P, Kim D, Kanarek N, Pacold ME, Chen WW, et al:
Dihydropyrimidine accumulation is required for the
epithelial-mesenchymal transition. Cell. 158:1094–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang Y, Liao L, Shrestha C, Ji S, Chen Y,
Peng J, Wang L, Liao E and Xie Z: Reduced expression of E-cadherin
and p120-catenin and elevated expression of PLC-γ1 and PIKE are
associated with aggressiveness of oral squamous cell carcinoma. Int
J Clin Exp Pathol. 8:9042–9051. 2015.
|
|
4
|
Rajwar YC, Jain N, Bhatia G, Sikka N, Garg
B and Walia E: Expression and significance of cadherins and its
subtypes in development and progression of oral cancers: a review.
J Clin Diagn Res. 9:ZE05–ZE07. 2015.PubMed/NCBI
|
|
5
|
Soares MQ, Mendonça JA, Morais MO, Leles
CR, Batista AC and Mendonça EF: E-cadherin, β-catenin, and α2β1 and
α3β1 integrin expression in primary oral squamous cell carcinoma
and its regional metastasis. Histol Histopathol. 30:1213–1222.
2015.PubMed/NCBI
|
|
6
|
Wang C, Huang H, Huang Z, Wang A, Chen X,
Huang L, Zhou X and Liu X: Tumor budding correlates with poor
prognosis and epithelial-mesenchymal transition in tongue squamous
cell carcinoma. J Oral Pathol Med. 40:545–551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang C, Liu X, Huang H, Ma H, Cai W, Hou
J, Huang L, Dai Y, Yu T and Zhou X: Deregulation of Snai2 is
associated with metastasis and poor prognosis in tongue squamous
cell carcinoma. Int J Cancer. 130:2249–2258. 2012. View Article : Google Scholar
|
|
8
|
Wang C, Liu X, Chen Z, Huang H, Jin Y,
Kolokythas A, Wang A, Dai Y, Wong DT and Zhou X: Polycomb group
protein EZH2-mediated E-cadherin repression promotes metastasis of
oral tongue squamous cell carcinoma. Mol Carcinog. 52:229–236.
2013. View
Article : Google Scholar
|
|
9
|
Liu X, Wang C, Chen Z, Jin Y, Wang Y,
Kolokythas A, Dai Y and Zhou X: MicroRNA-138 suppresses
epithelial-mesenchymal transition in squamous cell carcinoma cell
lines. Biochem J. 440:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu D, Deng Q, Sun L, Wang T, Yang Z, Chen
H, Guo L, Liu Y, Ma Y, Guo N, et al: A Her2-let-7-β2-AR circuit
affects prognosis in patients with Her2-positive breast cancer. BMC
Cancer. 15:8322015. View Article : Google Scholar
|
|
11
|
Yang EV, Kim SJ, Donovan EL, Chen M, Gross
AC, Webster Marketon JI, Barsky SH and Glaser R: Norepinephrine
upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor
cell lines: implications for stress-related enhancement of tumor
progression. Brain Behav Immun. 23:267–275. 2009. View Article : Google Scholar :
|
|
12
|
Barbieri A, Bimonte S, Palma G, Luciano A,
Rea D, Giudice A, Scognamiglio G, La Mantia E, Franco R, Perdonà S,
et al: The stress hormone norepinephrine increases migration of
prostate cancer cells in vitro an in vivo. Int J Oncol. 47:527–534.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi M, Yang Z, Hu M, Liu D, Hu Y, Qian L,
Zhang W, Chen H, Guo L, Yu M, et al: Catecholamine-induced
β2-adrenergic receptor activation mediates desensitization of
gastric cancer cells to trastuzumab by upregulating MUC4
expression. J Immunol. 190:5600–5608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Deng YT, Liu J, Wang YQ, Yi TW,
Huang BY, He SS, Zheng B and Jiang Y: Norepinephrine induced
epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.
J Cancer Res Clin Oncol. 142:423–435. 2016. View Article : Google Scholar
|
|
15
|
Lu YJ, Geng ZJ, Sun XY, Li YH, Fu XB, Zhao
XY and Wei B: Isoprenaline induces epithelial-mesenchymal
transition in gastric cancer cells. Mol Cell Biochem. 408:1–13.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shan T, Cui X, Li W, Lin W, Li Y, Chen X
and Wu T: Novel regulatory program for norepinephrine-induced
epithelial-mesenchymal transition in gastric adenocarcinoma cell
lines. Cancer Sci. 105:847–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: a central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye X, Tam WL, Shibue T, Kaygusuz Y,
Reinhardt F, Ng Eaton E and Weinberg RA: Distinct EMT programs
control normal mammary stem cells and tumour-initiating cells.
Nature. 525:256–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin JF, Jin FJ, Li N, Guan HT, Lan L, Ni H
and Wang Y: Adrenergic receptor β2 activation by stress promotes
breast cancer progression through macrophages M2 polarization in
tumor microenvironment. BMB Rep. 48:295–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braadland PR, Ramberg H, Grytli HH and
Taskén KA: β-Adrenergic receptor signaling in prostate cancer.
Front Oncol. 4:3752015. View Article : Google Scholar
|
|
21
|
Bravo-Calderón DM, Oliveira DT, Marana AN,
Nonogaki S, Carvalho AL and Kowalski LP: Prognostic significance of
beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer
Biomark. 10:51–59. 2011–2012. View Article : Google Scholar
|
|
22
|
Shang ZJ, Liu K and Liang DF: Expression
of beta2-adrenergic receptor in oral squamous cell carcinoma. J
Oral Pathol Med. 38:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bernabé DG, Tamae AC, Biasoli ÉR and
Oliveira SH: Stress hormones increase cell proliferation and
regulates interleukin-6 secretion in human oral squamous cell
carcinoma cells. Brain Behav Immun. 25:574–583. 2011. View Article : Google Scholar
|
|
24
|
Yadav A, Kumar B, Datta J, Teknos TN and
Kumar P: IL-6 promotes head and neck tumor metastasis by inducing
epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling
pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim MS, Lee WS, Jeong J, Kim SJ and Jin W:
Induction of metastatic potential by TrkB via activation of
IL6/JAK2/STAT3 and I3K/AKT signaling in breast cancer. Oncotarget.
6:40158–40171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Ren G, Wang T, Chen Y, Gong C, Bai
Y, Wang B, Qi H, Shen J, Zhu L, et al: Aberrantly expressed Fra-1
by IL-6/STAT3 transactivation promotes colorectal cancer
aggressiveness through epithelial-mesenchymal transition.
Carcinogenesis. 36:459–468. 2015. View Article : Google Scholar : PubMed/NCBI
|
